BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7314262)

  • 1. A clinical and pathologic study of 34 sarcomas of the uterus.
    Kenda R; De Palo G; Andreola S; Bandieramonte G; Lupi G; Musumeci R
    Tumori; 1981 Aug; 67(4):341-8. PubMed ID: 7314262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.
    Vongtama V; Karlen JR; Piver SM; Tsukada Y; Moore RH
    AJR Am J Roentgenol; 1976 Jan; 126(1):139-47. PubMed ID: 175673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the science: Uterine sarcomas: From pathology to practice.
    Shushkevich A; Thaker PH; Littell RD; Shah NA; Chiang S; Thornton K; Hensley ML; Slomovitz BM; Holcomb KM; Leitao MM; Toboni MD; Powell MA; Levine DA; Dowdy SC; Klopp A; Brown J
    Gynecol Oncol; 2020 Oct; 159(1):3-7. PubMed ID: 32839026
    [No Abstract]   [Full Text] [Related]  

  • 4. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas.
    Wolfson AH; Wolfson DJ; Sittler SY; Breton L; Markoe AM; Schwade JG; Houdek PV; Averette HE; Sevin BU; Penalver M
    Gynecol Oncol; 1994 Jan; 52(1):56-62. PubMed ID: 8307502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine sarcomas 2013.
    Sutton G
    Gynecol Oncol; 2013 Jul; 130(1):3-5. PubMed ID: 23769183
    [No Abstract]   [Full Text] [Related]  

  • 6. [Postoperative radiotherapy of uterine sarcoma: a multicentric retrospective study].
    Champetier C; Hannoun-Levi JM; Resbeut M; Azria D; Salem N; Tessier E; Ellis S; Cowen D;
    Cancer Radiother; 2011 Apr; 15(2):89-96. PubMed ID: 20674447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcomas of the uterus: a clinicopathologic study of 119 patients.
    Kahanpää KV; Wahlström T; Gröhn P; Heinonen E; Nieminen U; Widholm O
    Obstet Gynecol; 1986 Mar; 67(3):417-24. PubMed ID: 3945454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with sarcoma of the uterus.
    Bokhman JV; Yakovleva IA; Urmanchejeva AF
    Eur J Gynaecol Oncol; 1990; 11(3):225-31. PubMed ID: 2209643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
    Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
    Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histopathological, clinical and prognostic aspects of smooth-muscle tumors of the uterus (cellular myoma, leiomyosarcoma, endometrial stromal sarcoma)].
    De Giacomo G; Palla G; Paparatti L; Villani L; Moneta E
    Minerva Ginecol; 1988 Feb; 40(2):73-81. PubMed ID: 3399122
    [No Abstract]   [Full Text] [Related]  

  • 11. Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007.
    Gao Y; Meng H; Zhang Y; Jiao T; Hui N
    Int J Clin Exp Pathol; 2014; 7(4):1616-24. PubMed ID: 24817958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
    Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
    Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.
    Rovirosa A; Ascaso C; Ordi J; Abellana R; Arenas M; Lejarcegui JA; Pahisa J; Puig-Tintoré LM; Mellado B; Armenteros B; Iglesias X; Biete A
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1320-9. PubMed ID: 11955745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases.
    Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Cosio S; Tisi G; Lissoni A; Ferrero AM; Cristofani R
    Eur J Gynaecol Oncol; 2002; 23(4):295-9. PubMed ID: 12214727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine sarcoma: analysis of prognostic variables in 71 cases.
    Wheelock JB; Krebs HB; Schneider V; Goplerud DR
    Am J Obstet Gynecol; 1985 Apr; 151(8):1016-22. PubMed ID: 2984936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.
    Sorbe B; Johansson B
    Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine sarcoma. Clinico-pathological characteristics and outcome.
    Sait HK; Anfinan NM; El Sayed ME; Alkhayyat SS; Ghanem AT; Abayazid RM; Sait KH
    Saudi Med J; 2014 Oct; 35(10):1215-22. PubMed ID: 25316466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A clinical analysis of 153 uterine sarcomas].
    Bai P; Sun J; Chao H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.